Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Jan. 18, 2017. Jeff Shuren.

Executive Summary

Check out what FDA device director Jeff Shuren had to say about his center's path to simplicity, one part of CDRH's three-year strategic priorities.

"Too often, as new issues arise, we add on new policies and processes, which creates additional steps, rather than sometimes going back, revisiting, and maybe redesigning what we do so we can achieve our objectives more efficiently." –Jeff Shuren, Director, US FDA Center for Devices and Radiological Health

> Find out more: Podcast Exclusive: Jeff Shuren Discusses FDA's Device Strategic Priorities

Click here for a free trial of Medtech Insight


Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122063

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel